Evaluation The role of Trefoil Factor1 as early stage biomarker in patients with Nephrolithiasis

Authors

  • “Mohammed Abdullah Ajeel
  • Zaid Mohammed Mubarak Al-Mahdawi

DOI:

https://doi.org/10.25130/tjps.v23i9.807

Abstract

Nephrolithiasis is a public health problem that affect large scale of
peoples around the world. naturally, there are many substances ,proteins,
lipids, glycosaminoglycans and inorganic compounds, work as kidney
stone inhibitors in the normal renal tubular fluid that inhibit crystal
growth, aggregation, and/or adhesion to renal surfaces, among this
inhibitors we investigate the concentration of trefoil factor 1 (TFF1) as a
stone formation inhibitor and kidney injury biomarker in serum of 75
kidney stone patients and 15 healthy subjects using ELISA technique.
The results shows no significant changes within patients groups while
shows that TFF1 levels were significantly increased in stone patients
when compared with the healthy controls (P≤0.05), which support the
fact that it could use as early marker of kidney injury (KI) .The results
also revealed no significant changes within patients groups while there
was a significant changes between patients and controls for both blood
urea and serum creatinine levels in renal stone patients in comparison to
the apparently healthy control subjects (P ≤0.05). Further investigation
are needed to show the inhibitory effect of TFF1 in urine of kidney stone
patients.

Downloads

Published

2023-01-30

How to Cite

“Mohammed Abdullah Ajeel, & Zaid Mohammed Mubarak Al-Mahdawi. (2023). Evaluation The role of Trefoil Factor1 as early stage biomarker in patients with Nephrolithiasis. Tikrit Journal of Pure Science, 23(9), 16–19. https://doi.org/10.25130/tjps.v23i9.807

Issue

Vol. 23 No. 9 (2018)

Section

Articles

License

Copyright (c) 2023 Tikrit Journal of Pure Science

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.